Dendritic cells with reduced or inhibited formation of the ESCRT1 and uses thereof

摘要

The present invention relates to dendritic cells with reduced or suppressed ESCRT1 formation and uses thereof, and more particularly, to dendritic cells with reduced or suppressed gene expression of VPS37 constituting ESCRT1, and uses thereof, and the like. The dendritic cells with reduced or inhibited ESCRT1 formation of the present invention can be used for the prevention or treatment of inflammatory diseases, and can be administered intranasally and used as a drug for the prevention or treatment of allergic respiratory diseases, rhinitis and asthma. It can be used in medicines and quasi-drugs for alleviating the symptoms of